GROUND-BREAKING
ACQUISITIONS

SPECIALIZING IN LEVERAGED BUYOUTS

SPECIALIZING IN LEVERAGED BUYOUTS

WE'RE A MULTINATIONAL PRIVATE EQUITY FIRM, HEADQUARTERED IN NEW YORK

LATEST<BR>NEWS

LATEST
NEWS

New Development In Europe

New Development In Europe

Milost Global Opens A London Office

LATEST<BR>NEWS

LATEST
NEWS

Capital Bank & Soyombo Insurance

Capital Bank & Soyombo Insurance

Announce a Milost Global financing.

GLOBAL<br>PRESENCE

GLOBAL
PRESENCE

REVOLUTIONARY INVESTMENT STRATEGIES

REVOLUTIONARY INVESTMENT STRATEGIES

Our global teams work together across different industries, economies and political climates

UNIQUE<br>APPROACH

UNIQUE
APPROACH

WHAT DISTINGUISHES US

WHAT DISTINGUISHES US

Aligning incentives through equity ownership & preserving the entrepreneurial orientation

Milost Global Inc is at the intersection of creative investing and value creation

OUR PORTFOLIO
Read More +

OUR PORTFOLIO

We are a buyout firm and our unique approach aligns incentives through equity ownership and preserves the entrepreneurial orientation that distinguishes the most successful buyout firm.

OUR STRATEGY
Read More +

OUR STRATEGY

We provide equity finance to privately owned companies through a range of transaction types, including MBOs, MBIs, LBOs, equity release, expansion capital and public-to-private deals.

OUR TEAM
Read More +

OUR TEAM

Years of private equity experience, deep industry knowledge, and unparalleled networks of resources enable our team of approximately investment professionals.

Inspyr Therapeutics

Inspyr Therapeutics

Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics.

Inspyr is developing prodrug therapeutics for some of the most challenging diseases in oncology, harnessing a cutting-edge platform technology to deliver a cytotoxin safely and efficiently directly to tumors.

Mipsagargin, our lead agent, is in human clinical trials for patients with several different tumor types:

  • Hepatocellular carcinoma, or liver cancer
  • Oriental Femab Mining
  • Glioblastoma, or brain cancer
  • Prostate cancer

Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.

Your Global Investment PartnerĀ 
TOP